Regadenoson
NDC 68083-175, Regadenoson, injection, solution, from Gland Pharma Limited.
- Product NDC
- 68083-175
- Status
- Listed
- Labeler
- Gland Pharma Limited
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207320
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68083-175 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- REGADENOSON.08 mg/mL
Pharmacologic classes
Adenosine Receptor Agonists [MoA]; Pharmacologic Cardiac Stress Test Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68083-175-10 | 68083017510 | 10 VIAL in 1 CARTON (68083-175-10) / 5 mL in 1 VIAL (68083-175-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/5e4109f0-4875-4f8e-b70d-4055b3a785a3
Use it
Look up 68083-175 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68083-175 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68083-175. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.